Skip to main content
. Author manuscript; available in PMC: 2012 Jan 27.
Published in final edited form as: Mol Cancer Ther. 2008 Apr;7(4):890–896. doi: 10.1158/1535-7163.MCT-07-0518

Figure 2. Effect of sorafenib therapy on STS growth inhibition.

Figure 2

STS cell lines in log phase growth were incubated with sorafenib at the indicated concentrations for 4 days. Cell viability was determined using the Cell Counting Kit 8 in 96 well plates. Points, mean percent absorbance of three replicate wells relative to untreated controls. The experiments were repeated on three separate occasions with similar results.